Chen Yun-Lung, serving as the Vice President of Business Development for Ambarella Inc. (NASDAQ: AMBA), completed a transaction involving the sale of 9,856 ordinary shares on June 12, 2026. The aggregate value of these sales reached $660,943. The transaction was executed at a weighted average price of $67.06 per share. Individual sale prices within this transaction ranged narrowly from $67.06 to $67.07 per share. Following this divestment, Mr. Chen Yun-Lung's direct ownership of Ambarella ordinary shares stands at 66,515 shares.
This insider activity occurs as Ambarella's stock trades near the $67.12 mark. Market analysis suggests this price point sits above the company's estimated Fair Value, placing the stock on lists identifying it as overvalued. Ambarella, a semiconductor firm with a market capitalization of $2.97 billion, has demonstrated robust revenue expansion. Over the trailing twelve months, revenue grew by 28%. Despite this top-line strength, the company has not yet achieved profitability, reporting a negative earnings per share (EPS) of $1.62.
Recent corporate developments provide additional context to the insider transaction. Ambarella recently reported first-quarter financial results that exceeded consensus expectations. The company posted non-GAAP earnings of $0.11 per share on revenue of $100.4 million. These figures surpassed analyst estimates of $0.10 per share and $100 million in revenue, respectively. Furthermore, Ambarella maintained its full-year revenue guidance, projecting growth between 10% and 15%.
Strategic partnerships also feature prominently in the company's recent narrative. Ambarella announced a significant long-term agreement with Hanwha Group. This deal involves multiple AI System-on-Chip (SoC) platforms and is valued at $800 million over a ten-year period. The announcement has prompted varied responses from the analyst community.
Northland reaffirmed an Outperform rating on Ambarella, setting a price target of $101. Rosenblatt also maintained a Buy rating, with a higher price target of $120. In contrast, BofA Securities raised its price target to $96 from $72 but kept a Neutral rating. BofA highlighted growth potential in edge AI applications as a key factor. Stifel increased its price target to $106 from $90, maintaining a Buy rating. Stifel cited Ambarella's strong positioning in the AI market, particularly as the company shifts toward edge inferencing.
However, not all analyst sentiment is uniformly positive. Summit Insights downgraded the stock from Buy to Hold. The downgrade was attributed to supply chain risks anticipated in the latter half of 2026. Despite the downgrade, Summit Insights acknowledged the company's efforts in securing long-term agreements and reducing DRAM requirements. This mix of ratings reflects a complex outlook for Ambarella, balancing strong strategic moves and revenue growth against valuation concerns and operational risks.